Your browser doesn't support javascript.
loading
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian.
Afiliação
  • Rubin DT; Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA.
  • Dotan I; Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • DuVall A; Tyler Research Institute, Tyler, TX, USA.
  • Bouhnik Y; Institut National de la Santé et Recherche Médicale et Université Paris Diderot, Paris Hôpital Beaujon, AP-HP, Paris, France.
  • Radford-Smith G; Royal Brisbane and Women's Hospital, University of Queensland Faculty of Medicine, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
  • Higgins PDR; Department of Internal Medicine, The University of Michigan, Ann Arbor, MI, USA.
  • Mishkin DS; Atrius Health, Gastroenterology Division, Weymouth, MA, USA.
  • Arrisi P; Roche Products, Welwyn Garden City, UK.
  • Scalori A; Roche Products, Welwyn Garden City, UK.
  • Oh YS; Genentech, South San Francisco, CA, USA.
  • Tole S; Genentech, South San Francisco, CA, USA.
  • Chai A; Genentech, South San Francisco, CA, USA.
  • Chamberlain-James K; Roche Products, Welwyn Garden City, UK.
  • Lacey S; Roche Products, Welwyn Garden City, UK.
  • McBride J; Genentech, South San Francisco, CA, USA.
  • Panés J; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute, Biomedical Research Networking Center in Hepatic and Digestive Diseases, Barcelona, Spain. Electronic address: JPANES@clinic.cat.
Lancet Gastroenterol Hepatol ; 7(1): 17-27, 2022 01.
Article em En | MEDLINE | ID: mdl-34798036

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Anticorpos Monoclonais Humanizados / Adalimumab Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Anticorpos Monoclonais Humanizados / Adalimumab Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos